Expand this Topic clickable element to expand a topic
Skip to content
Optica Publishing Group

Study of antiangiogenic drugs by fluorescence imaging and spectroscopy of a contrast agent in mice

Not Accessible

Your library or personal account may give you access

Abstract

We used two fluorescence techniques based on the Indocyanine Green contrast agent to study the effectiveness of antiangionenic drugs in mice. To this purpose, the volume of the active vasculature in different tumor models implanted in mice was assessed by means of a low noise fluorescence imaging setup and by a photon counting system working in transmittance geometry. Using a first tumor model (carcinoma MDA-MB-435) we observed that mice treated with a Vascular Disrupting Agent (ZD6126) showed a reduction in fluorescence emission of the contrast agent with respect to control mice. This was a clear indication of the vascular shutdown that took place in tumors. The effectiveness of the treatment was also confirmed by histological sections. Then, in a second experiment we considered a second tumor model (carcinoma 1A9-VS1) overexpressing the Vascular Endotelial Growth Factor (VEGF121), which is used by tumor cells to promote angiogenesis. We measured the Indocyanine Green fluorescence in mice treated with an antioangiogenic drug (Avastin™) and in control mice. In tumors of treated mice we observed an ICG emission lower than the one detected in control mice. This demonstrated that VEGF activity was effectively blocked by the treatment with Avastin. In conclusion, ICG fluorescence provides a simple and reliable way to assess the effectiveness of vascular targeting therapies. Measurements of the fluorescence signal can be repeated every 24 hours, thus allowing oncologists to perform longitudinal studies on the same animals.

© 2007 SPIE

PDF Article
More Like This
Fluorescent imaging of vascular shutdown in-vivo

Gianluca Valentini, Cosimo D’Andrea, Raffaele Ferrari, Antonio Pifferi, Rinaldo Cubeddu, Michele Martinelli, Claudia Natoli, Paolo Ubezio, and Raffaella Giavazzi
TuC3 Biomedical Topical Meeting (BIOMED) 2006

Dynamic Fluorescence Imaging For The Detection of Vascular Changes in Anti-Angiogenic Drug Therapy

Jonghwan Lee, Thomas Pöschinger, Sonia L. Hernandez, Jianzhong Huang, Tessa Johung, Jessica Kandel, Darrell J. Yamashiro, and Andreas H. Hielscher
JMA74 Biomedical Optics (BIOMED) 2010

Molecular targeting as a contrast agent mechanism for fluorescence endoscopy

A J. Healey, R. Bendiksen, A Tornes, and E. Johannesen
6626_23 European Conference on Biomedical Optics (ECBO) 2007

Select as filters


Select Topics Cancel
© Copyright 2024 | Optica Publishing Group. All Rights Reserved